Green Cross to commercialize Tamiflu with Estechpharma.

Published: 2005-12-07 06:58:00

Updated: 2005-12-07 06:58:00

Green Cross is going to introduce Tamiflu generic product in association with Estechpharma where the main substance was succeeded in its production, oseltamivir phosphate, and the sample and data for its manufacturing process with quality controls were already submitted to the KFDA.

Green Cros...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK